Pankaj Mohan, Director, 10% Owner at Outlook Therapeutics, Inc. (OTLK), bought 8,000 shares at $0.68 ($5K) on 2019-01-15, disclosed to the SEC on 2019-01-17.
Open-market purchase of $5k OTLK by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SONN | BUY | 2021-06-09 | $50K | — | Filing → |
| SONN | BUY | 2020-06-12 | $10K | — | Filing → |
| ONS | SELL | 2018-01-05 | $268K | — | Filing → |